Mouse anti-STXBP1 monoclonal antibody for ELISA, WB, IHC
STXBP1 (Syntaxin Binding Protein 1) is a Protein Coding gene. Diseases associated with STXBP1 include epileptic encephalopathy, early infantile, 4 and ohtahara syndrome. Among its related pathways are Metabolism and Neurotransmitter Release Cycle. GO annotations related to this gene include poly(A) RNA binding and protein kinase binding. An important paralog of this gene is STXBP3. This gene encodes a syntaxin-binding protein. The encoded protein appears to play a role in release of neurotransmitters via regulation of syntaxin, a transmembrane attachment protein receptor. Mutations in this gene have been associated with infantile epileptic encephalopathy-4. Alternatively spliced transcript variants have been described.
This gene encodes a syntaxin-binding protein. The encoded protein appears to play a role in release of neurotransmitters via regulation of syntaxin, a transmembrane attachment protein receptor. Epileptic encephalopathy, early infantile, 4 (EIEE4) [MIM:612164]: A severe form of epilepsy characterized by frequent tonic seizures or spasms beginning in infancy with a specific EEG finding of suppression-burst patterns, characterized by high-voltage bursts alternating with almost flat suppression phases. Affected individuals have neonatal or infantile onset of seizures, profound mental retardation, and MRI evidence of brain hypomyelination. Note=The disease is caused by mutations affecting the gene represented in this entry. Syntaxin-binding protein 1 is a protein that in humans is encoded by the STXBP1 gene. 0The function about STXBP1 antigen include SNARE binding; identical protein binding; syntaxin-1 binding; syntaxin-2 binding.
Acetylcholine Neurotransmitter Release Cycle, organism-specific biosystem; Dopamine Neurotransmitter Release Cycle, organism-specific biosystem; EGFR1 Signaling Pathway, organism-specific biosystem; Effects of Botulinum toxin, organism-specific biosystem; GABA synthesis, release, reuptake and degradation, organism-specific biosystem; Glutamate Neurotransmitter Release Cycle, organism-specific biosystem; Insulin Signaling, organism-specific biosystem.
Naganuma, T; Maekawa, M; et al. Effects of S-nitroso-cysteine on proteins that regulate exocytosis in PC12 cells: Inhibitory effects on translocation of synaptophysin and ADP-ribosylation of GTP-binding proteins. JAPANESE JOURNAL OF PHARMACOLOGY 84:391-398(2000).
Alexiades, MR; Cepko, CL; et al. Subsets of retinal progenitors display temporally regulated and distinct biases in the fates of their progeny. DEVELOPMENT 124:1119-1131(1997).
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody.